Stephen Lockwood, MD
Dermatology · Brandon, FLNPI 1396129128
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 92.0% of the total across 254 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 21.0% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,763, 5.3 times the $336 reported in 2019.
Across 254 payments — averaging $23.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arcutis Biotherapeutics, Inc.$1K
- Johnson & Johnson$912
- Novartis$721
- AbbVie$708
- Lilly USA, LLC$270
- Hill Dermaceuticals, Inc.$266
- plus $2K from 25 others
Across 431 payments — averaging $2741.46 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Sanofi Pasteur Inc.$410K
- Sanofi US Services Inc.$209K
- Incyte Corporation$208K
- AbbVie$141K
- Eli Lilly$121K
- E.r. Squibb & Sons, L.L.C.$94K
What the payments were for
- Food & beverage$5,37892%
- Education$4658%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arcutis Biotherapeutics, Inc. | 54 | $1,227 |
| Johnson & Johnson(2 entities) | 31 | $912 |
| Novartis | 33 | $721 |
| AbbVie | 41 | $708 |
| Lilly USA, LLC | 14 | $270 |
| Hill Dermaceuticals, Inc. | 1 | $266 |
| Incyte Corporation | 9 | $248 |
| Sun Pharmaceutical Industries Inc. | 10 | $197 |
| Regeneron Healthcare Solutions, Inc. | 7 | $159 |
| Galderma Laboratories, L.p. | 8 | $142 |
| LEO Pharma Inc. | 5 | $123 |
| Sanofi | 5 | $106 |
| Amgen | 5 | $97 |
| Mayne Pharma Commercial LLC | 4 | $89 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 4 | $71 |
| Boehringer Ingelheim | 3 | $70 |
| Cipher Pharmaceuticals US LLC | 1 | $59 |
| Pfizer | 2 | $46 |
| Merz North America, Inc. | 2 | $44 |
| E.r. Squibb & Sons, L.L.C. | 2 | $37 |
| Verrica Pharmaceuticals Inc. | 2 | $33 |
| Almirall LLC | 1 | $31 |
| Mallinckrodt Hospital Products Inc. | 1 | $29 |
| UCB, Inc. | 1 | $29 |
| Sebela Pharmaceuticals Inc. | 2 | $29 |
| ANI Pharmaceuticals, Inc. | 1 | $25 |
| Biofrontera Inc. | 1 | $20 |
| EPI Health, LLC | 1 | $20 |
| Paratek Pharmaceuticals, Inc. | 1 | $19 |
| Boston Scientific | 1 | $13 |
| Organon | 1 | $3 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,843 in reported general payments places this provider in the 70th percentile of 1,147 dermatology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cosentyx Unoready PenSecukinumab | 12 | $114,127 |
| Dupixent PenDupilumab | 11 | $40,731 |
| Clobetasol Propionate | 82 | $2,802 |
| Fluorouracil | 20 | $1,141 |
| Doxycycline Hyclate | 54 | $713 |
| ValacyclovirValacyclovir Hcl | 21 | $696 |
| Ketoconazole | 42 | $680 |
| Betamethasone Dipropionate | 17 | $643 |
| Triamcinolone Acetonide | 79 | $619 |
| Hydrocortisone | 36 | $145 |
| Minoxidil | 17 | $142 |
| Mupirocin | 11 | $82 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Brandon
- Francisco KerdelMiami$2.1M
- Brad GlickMargate$2M
- Robert KirsnerMiami$1.4M
- John MinniStuart$1.4M
- Gil YosipovitchMiami$1M
- Shino Bay AguileraFt Lauderdale$1M
- Robert SnyderPembroke Pines$1M
- Marc IngleseTallahassee$989K
- Jeremy GreenCoral Gables$952K
- Mercedes GonzalezMiami$943K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.